

Any decision to participate in our patient funded experimental protocols is completely voluntary.Man Experiences Breathing “Miracle” in Treating COPD with Stem Cell Therapy It is important for potential patients to do their own research based on the options that we present so that one can make an informed decision. We do not claim that these treatments work for any listed nor unlisted condition, intended or implied. The Hawaii Stem Cell Treatment Center does not claim that any applications or potential applications using these autologous stem cell treatments are approved by the FDA or are even effective. The Hawaii Stem Cell Treatment Center is offering patient funded research to treat individual patients with their own autologous stem cells and is not involved in the use or manufacture of any investigational drugs. All statements and opinions provided by this website are provided for educational and informational purposes only and we do not diagnose or treat via this website or via telephone. No statements or treatments on this website have been evaluated or approved by the FDA.

The Hawaii Stem Cell Treatment Center is not offering stem cell therapy as a cure for any condition, disease or injury. Plastic Surgery and medicine are not an exact science and can be unpredictable based on patient health and anatomy. We in no way imply or indicate that you will have a similar outcome. Note: All photos, videos and testimonials on this web site that depict actual patients or outcomes do not indicate you will have a similar result, as individual results vary. If you are interested in further information and possibly to be a candidate for our study for COPD or lung disease please contact us. Your results will be monitored and data recorded by a specialist in COPD. Patients go home the same day of the procedure. The entire procedure takes only a few hours and is performed under local anesthesia. This is given to the patient under our specific study protocol.Īt the Hawaii Stem Cell Treatment Center we use our network’s standardized SVF protocols for COPD. By using the patients own fat, we derive from the Stromal Vascular Fraction (SVF) or what may be termed “a stem cell broth” (which includes healing and growth factors). Our network has developed specific protocols under study to deploy mesenchymal stem cells derived from the patients own subcutaneous tissue and the fat layer.

There is modulation of the immune system and an anti inflammatory effect. Anti inflammatory effectsĬellular therapy may offer hope to these patients due to the regenerative power of these cells. COPD patients typically have a combination of both chronic bronchitis and emphysema. On the other hand, emphysema is characterized by destruction of the lung tissue. Chronic bronchitis is characterized with a daily cough and a lot of mucous production. There are two types of COPD, chronic bronchitis and emphysema. Treatments include bronchial dilators, steroids and exercise as well as supplemental oxygen. The patients suffer shortness of breath, asthma like symptoms, cough and sometimes even the ability to walk a flight of stairs. Also certain patients who have the disease may be predisposed to COPD, as they lack a certain enzyme since birth. This has been under study for the possible effects of stem cell therapy in regenerating the lung tissue damaged by smoking or chemical exposure. Regeneration of lung tissue with stem cell therapy
